Amphotericin B is Incompatible with Lipid Emulsions

Abstract

Get full access to this article

View all access options for this article.

References

Kirsh

Goldstein

Tarloff

Parris

Hook

Hanna

. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis 1988; 158: 1065–70.

Moreau

Milpied

Fayette

Ramée

J-F

Harousseau

. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutrogenic patients. J Antimicrob Chemother 1992; 30: 535–41.

Chavanet

Garry

Charlier

Caillot

Kisterman

D'Athis

. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected parients with candidiasis. BMJ 1992; 305: 921–5.

Vita

Schroeder

. Intralipid in prophylaxis of amphotericin B nephrotoxicity. Ann Pharmacother 1994; 28: 1182–3.

Smith

Strozyk

. Lack of nephrotoxocity with the administration of amphotericin B in a lipid emulsion. Ann Pharmacother 1994; 28: 1307–8.

Jurgens

DeLuca

Papadimitriou

. Compatibility of amphotericin B with certain large-volume parenterals. Am J Hosp Pharm 1981; 38: 377–8.

Margosis

Aszalos

. Quantitation of amphotericin by reversephase high-performance liquid chromatography. J Pharm Sci 1984; 73: 835–8.